Form 4: ON24 CEO Sharan Sharat Reports Stock Transactions

Sentiment:

Statement of Changes in Beneficial Ownership


ON24 CEO Sharan Sharat reported the exercise of stock options and subsequent sale of shares under a pre-arranged trading plan.

Summary

  • Sharan Sharat, President and Chief Executive Officer of ON24, Inc., reported transactions involving the company's common stock.
  • On November 24, 2025, Sharat acquired 53,459 shares of common stock through the exercise of stock options at an exercise price of $0.89 per share.
  • Immediately following the option exercise on November 24, 2025, Sharat disposed of 32,211 shares of common stock at a weighted average price of $5.3033 per share.
  • The sale transactions occurred within a price range of $5.23 to $5.425 per share.
  • These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Sharat on May 14, 2025.
  • Following these reported transactions, Sharat beneficially owns 3,613,147 shares of ON24, Inc. common stock directly.
  • The stock options exercised were fully vested and exercisable, with an expiration date of January 4, 2026.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, even though it was pre-planned under a 10b5-1 plan. While the plan mitigates concerns of opportunistic selling, any executive share disposition can be interpreted cautiously by the market.

Positives

  • The exercise of stock options at a significantly lower price ($0.89) compared to the sale price ($5.3033) indicates a profitable realization for the executive.
  • The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned and systematic approach to managing personal holdings rather than opportunistic selling.

Negatives

  • The disposition of shares by a key executive, even under a 10b5-1 plan, can sometimes be perceived by investors as a lack of confidence or a move to diversify personal holdings.

Risks

  • Insider selling, even if pre-planned, can sometimes lead to negative market sentiment or speculation regarding the company's future prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders may interpret the CEO's sale of shares as a signal, potentially influencing their investment decisions, despite the pre-planned nature of the transaction.

Key Dates

DateDescription
05/14/2025Date Rule 10b5-1 trading plan was adopted by Sharan Sharat.
11/24/2025Date of stock option exercise and subsequent sale of common stock.
11/25/2025Date the Form 4 was signed.
01/04/2026Expiration date of the exercised stock options.

Recommendation

hold

The filing details a routine insider transaction involving the exercise of stock options and subsequent sale of a portion of the acquired shares under a pre-arranged 10b5-1 trading plan. While insider selling can sometimes be a negative signal, the planned nature of this transaction reduces immediate concerns about a lack of confidence. It does not provide new fundamental information about the company's operations or future prospects that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while monitoring future company developments.

Keywords

ON24, ONTF, Sharan Sharat, Form 4, Insider Trading, Stock Options, 10b5-1 Plan, Beneficial Ownership, Equity Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.